Brice Nativel

952 total citations
20 papers, 742 citations indexed

About

Brice Nativel is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Infectious Diseases. According to data from OpenAlex, Brice Nativel has authored 20 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Infectious Diseases. Recurrent topics in Brice Nativel's work include Lipoproteins and Cardiovascular Health (9 papers), Mosquito-borne diseases and control (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Brice Nativel is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Mosquito-borne diseases and control (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Brice Nativel collaborates with scholars based in France, Réunion and South Africa. Brice Nativel's co-authors include Wildriss Viranaïcken, Gilles Lambert, Olivier Meilhac, Stéphane Ramin‐Mangata, Valentin Blanchard, Kévin Chemello, Philippe Desprès, Gilles Gadéa, Chaker El Kalamouni and Pascale Krejbich‐Trotot and has published in prestigious journals such as PLoS ONE, The Journal of Comparative Neurology and Scientific Reports.

In The Last Decade

Brice Nativel

20 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brice Nativel France 16 246 160 157 157 140 20 742
Ningwen Tai United States 21 189 0.8× 608 3.8× 50 0.3× 304 1.9× 106 0.8× 29 1.3k
Nicolette Huijkman Netherlands 16 309 1.3× 516 3.2× 181 1.2× 114 0.7× 130 0.9× 31 1.2k
Natalia Smirnova France 15 152 0.6× 647 4.0× 58 0.4× 173 1.1× 77 0.6× 22 1.1k
Merlin Nanayakkara Italy 22 325 1.3× 382 2.4× 92 0.6× 247 1.6× 56 0.4× 41 1.3k
Hannu Turpeinen Finland 18 179 0.7× 233 1.5× 44 0.3× 281 1.8× 40 0.3× 33 879
Jeffrey B. Brown United States 17 180 0.7× 346 2.2× 36 0.2× 268 1.7× 69 0.5× 36 1.0k
Hirotake Sakuraba Japan 13 139 0.6× 214 1.3× 30 0.2× 140 0.9× 99 0.7× 85 723
Joanne A. O’Donnell Australia 18 104 0.4× 664 4.2× 146 0.9× 509 3.2× 169 1.2× 29 1.3k
Sabina Davidsson Sweden 19 191 0.8× 235 1.5× 54 0.3× 184 1.2× 29 0.2× 44 965
Thomas C. Sodeman United States 12 121 0.5× 256 1.6× 93 0.6× 60 0.4× 51 0.4× 42 745

Countries citing papers authored by Brice Nativel

Since Specialization
Citations

This map shows the geographic impact of Brice Nativel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brice Nativel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brice Nativel more than expected).

Fields of papers citing papers by Brice Nativel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brice Nativel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brice Nativel. The network helps show where Brice Nativel may publish in the future.

Co-authorship network of co-authors of Brice Nativel

This figure shows the co-authorship network connecting the top 25 collaborators of Brice Nativel. A scholar is included among the top collaborators of Brice Nativel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brice Nativel. Brice Nativel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
David, C., Cynthia Planesse, Jessica Patché, et al.. (2021). Lack of Neuroprotective Effects of High-Density Lipoprotein Therapy in Stroke under Acute Hyperglycemic Conditions. Molecules. 26(21). 6365–6365. 4 indexed citations
2.
Ramin‐Mangata, Stéphane, Aurélie Thedrez, Brice Nativel, et al.. (2021). Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells function. Atherosclerosis. 326. 47–55. 20 indexed citations
3.
Blanchard, Valentin, Kévin Chemello, Tim Hollstein, et al.. (2021). The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors. Cardiovascular Research. 118(9). 2103–2111. 20 indexed citations
4.
Zeller, Marianne, Gilles Lambert, Michel Farnier, et al.. (2020). PCSK9 levels do not predict severity and recurrence of cardiovascular events in patients with acute myocardial infarction. Nutrition Metabolism and Cardiovascular Diseases. 31(3). 880–885. 9 indexed citations
5.
Evison, Benny J., James T. Palmer, Gilles Lambert, et al.. (2020). A small molecule inhibitor of PCSK9 that antagonizes LDL receptor binding via interaction with a cryptic PCSK9 binding groove. Bioorganic & Medicinal Chemistry. 28(6). 115344–115344. 36 indexed citations
6.
Ramin‐Mangata, Stéphane, Matthieu Wargny, Matthieu Pichelin, et al.. (2019). Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes. Atherosclerosis. 293. 49–56. 17 indexed citations
7.
Nativel, Brice, Stéphane Ramin‐Mangata, Thomas Iwema, et al.. (2019). CD93 is a cell surface lectin receptor involved in the control of the inflammatory response stimulated by exogenous DNA. Immunology. 158(2). 85–93. 25 indexed citations
8.
Blanchard, Valentin, Mikaël Croyal, Stéphane Ramin‐Mangata, et al.. (2019). Reduced Lipoprotein(a) Associated With the Apolipoprotein E2 Genotype Confers Cardiovascular Protection in Familial Hypercholesterolemia. JACC Basic to Translational Science. 4(3). 425–427. 6 indexed citations
9.
Croyal, Mikaël, Jean-Christophe Le Bail, Elise F. Villard, et al.. (2018). PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate. Clinical Science. 132(10). 1075–1083. 35 indexed citations
10.
Blanchard, Valentin, et al.. (2018). PCSK9: from biology to clinical applications. Pathology. 51(2). 177–183. 37 indexed citations
11.
Blanchard, Valentin, Stéphane Ramin‐Mangata, Stéphanie Billon‐Crossouard, et al.. (2018). Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study. Journal of Lipid Research. 59(5). 892–900. 28 indexed citations
12.
Kalamouni, Chaker El, Étienne Frumence, Sandra Bos, et al.. (2018). Subversion of the Heme Oxygenase-1 Antiviral Activity by Zika Virus. Viruses. 11(1). 2–2. 47 indexed citations
13.
David, C., Steeve Bourane, Aurélie Catan, et al.. (2017). A hemorrhagic transformation model of mechanical stroke therapy with acute hyperglycemia in mice. The Journal of Comparative Neurology. 526(6). 1006–1016. 31 indexed citations
14.
Viranaïcken, Wildriss, Brice Nativel, Pascale Krejbich‐Trotot, et al.. (2017). ClearColi BL21(DE3)-based expression of Zika virus antigens illustrates a rapid method of antibody production against emerging pathogens. Biochimie. 142. 179–182. 19 indexed citations
15.
Nativel, Brice, C. David, Pierre Giraud, et al.. (2017). Porphyromonas gingivalis lipopolysaccharides act exclusively through TLR4 with a resilience between mouse and human. Scientific Reports. 7(1). 15789–15789. 109 indexed citations
16.
Thedrez, Aurélie, Dirk Blom, Stéphane Ramin‐Mangata, et al.. (2017). Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor). Arteriosclerosis Thrombosis and Vascular Biology. 38(3). 592–598. 74 indexed citations
17.
Nativel, Brice, Cynthia Planesse, Joël Couprie, et al.. (2016). Soluble expression of disulfide-bonded C-type lectin like domain of human CD93 in the cytoplasm of Escherichia coli. Journal of Immunological Methods. 439. 67–73. 6 indexed citations
18.
Frumence, Étienne, Marjolaine Roche, Pascale Krejbich‐Trotot, et al.. (2016). The South Pacific epidemic strain of Zika virus replicates efficiently in human epithelial A549 cells leading to IFN-β production and apoptosis induction. Virology. 493. 217–226. 125 indexed citations
19.
Planesse, Cynthia, et al.. (2015). Recombinant human HSP60 produced in ClearColi™ BL21(DE3) does not activate the NFκB pathway. Cytokine. 73(1). 190–195. 22 indexed citations
20.
Nativel, Brice, Manoj Kumar Gunasekaran, Cynthia Planesse, et al.. (2013). Soluble HMGB1 Is a Novel Adipokine Stimulating IL-6 Secretion through RAGE Receptor in SW872 Preadipocyte Cell Line: Contribution to Chronic Inflammation in Fat Tissue. PLoS ONE. 8(9). e76039–e76039. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026